CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 18:44 UTC

The Annexure

Desk Healthcare Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd

BSE 539206 GVBL INE574D01010
Healthcare Healthcare Pharmaceuticals & Biotechnology Biotechnology

Filing rhythm · 61 trading days

6 filings · 2 material · busiest 2026-08-14

What it files

Filings

6 in the window

  1. 17 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed herewith unaudited financial results for the quarter ended on 30th June, 2026.

    Company Update / Newspaper Publication View filing →

  2. 14 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Today I.E. 14Th August 2026

    Considered and approved the standalone Un-audited financial results of the company for the quarter ended on 30th June 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  3. 14 August 2026

    Results

    Results-Financial Results For Quarter Ended On 30 June 2026.

    Unaudited financial results for Quarter ended on 30 June 2026.

    Result / Financial Results View filing →

  4. 6 August 2026

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone) Of The Company For The Quarter Ended On June 30, 2026

    Genomic Valley Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve unaudited financial ....

    Board Meeting / Board Meeting View filing →

  5. 6 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 30th June, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  6. 29 June 2026

    Trading Window

    Closure of Trading Window

    Closure of trading window.

    Insider Trading / SAST / Closure of Trading Window View filing →